These treatments, which were initially created for glycemic management, have shown notable cardiovascular advantages, such as reducing the incidence of serious adverse cardiovascular events like heart attack, stroke, and cardiovascular death, particularly in high-risk individuals
doi: 10.1038/s41419-019-1549-6 71 TangZLiCKangBGaoGLiCZhangZ
Side Effects: Typically mild, such as slight bruising or temporary fatigue, with most patients reporting increased energy and well-being
Blood glucose levels were measured via an Accu-Chek Performa glucometer (Roche, Mannheim, Germany)
Tri-Fortify Liposomal Glutathione isn't justanother supplement
I understand tirzepatide is a dual-action GIP/GLP-1 agonist and may produce stronger weight loss results, while semaglutide has a longer track record